Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.200
-0.030 (-2.44%)
At close: Dec 5, 2025, 4:00 PM EST
1.210
+0.010 (0.83%)
After-hours: Dec 5, 2025, 5:01 PM EST
Coherus Oncology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 145 | 159 | 371 | 778 | 1,225 | 1,252 | |
| Market Cap Growth | 61.16% | -57.13% | -52.31% | -36.55% | -2.13% | -0.83% | |
| Enterprise Value | 8 | 361 | 718 | 971 | 1,176 | 1,166 | |
| Last Close Price | 1.20 | 1.38 | 3.33 | 7.92 | 15.96 | 17.38 | |
| PE Ratio | 2.28 | 5.58 | - | - | - | 9.47 | |
| Forward PE | - | - | - | - | - | 16.86 | |
| PS Ratio | 0.50 | 0.60 | 1.44 | 3.68 | 3.75 | 2.63 | |
| PB Ratio | 1.59 | -1.20 | -1.92 | -5.66 | 12.54 | 4.46 | |
| P/TBV Ratio | 3.79 | - | - | - | 13.02 | 4.51 | |
| P/FCF Ratio | - | - | - | - | - | 8.52 | |
| P/OCF Ratio | - | - | - | - | - | 8.12 | |
| EV/Sales Ratio | 0.03 | 1.35 | 2.79 | 4.60 | 3.60 | 2.45 | |
| EV/EBITDA Ratio | - | - | - | - | - | 7.32 | |
| EV/EBIT Ratio | - | - | - | - | - | 7.46 | |
| EV/FCF Ratio | - | - | - | - | - | 7.93 | |
| Debt / Equity Ratio | 0.62 | -2.26 | -2.49 | -3.50 | 4.29 | 1.48 | |
| Debt / EBITDA Ratio | - | - | - | - | - | 2.57 | |
| Debt / FCF Ratio | - | - | - | - | - | 2.84 | |
| Asset Turnover | 0.54 | 0.50 | 0.46 | 0.36 | 0.43 | 0.76 | |
| Inventory Turnover | 4.88 | 1.77 | 3.14 | 1.83 | 1.41 | 1.39 | |
| Quick Ratio | 1.19 | 0.88 | 1.14 | 2.17 | 3.27 | 4.79 | |
| Current Ratio | 1.24 | 1.21 | 1.43 | 2.75 | 3.64 | 5.27 | |
| Return on Equity (ROE) | - | - | - | - | -151.62% | 68.49% | |
| Return on Assets (ROA) | -10.26% | -10.94% | -21.75% | -27.68% | -21.68% | 15.63% | |
| Return on Capital (ROIC) | -29.64% | -25.98% | -38.31% | -37.35% | -27.15% | 19.66% | |
| Return on Capital Employed (ROCE) | -58.10% | -57.00% | -64.90% | -75.10% | -51.30% | 22.50% | |
| Earnings Yield | 106.84% | 17.93% | -64.15% | -37.52% | -23.43% | 10.56% | |
| FCF Yield | -62.18% | -12.86% | -47.16% | -31.01% | -3.16% | 11.73% | |
| Buyback Yield / Dilution | -2.22% | -21.95% | -21.30% | -2.89% | 9.63% | -14.08% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.